PRRSV : only one MLV per herd !

PRRSV : only one MLV per herd !

Scientific publication

PRRSV : only one MLV per herd !

In Europe, modified live vaccines (MLV) are commonly used to control porcine reproductive and respiratory syndrome virus (PRRSV) infection. However, they have been associated with safety issues such as reversion to virulence induced by mutation and/or recombination. On a French pig farm, we identified a field recombinant strain derived from two PRRSV-1 MLV. Estimation of transmission parameters revealed fastest transmission and longest duration of infectiousness for pigs exposed to the recombinant strain.

Eclercy et al., 2019c - SDRP field Recombinant Strain viruses-publication scientifique élevage et filière porcine
Maternally-derived antibodies reduce vaccine efficacy against PRRS virus

Maternally-derived antibodies reduce vaccine efficacy against PRRS virus

Scientific publication

Maternally-derived antibodies reduce vaccine efficacy against PRRS virus

We showed that MDNAs impair vaccine efficacy against PRRSV both in inoculated and contact piglets, probably by reducing vaccine replication.

IFNa may also interfere with PRRSV vaccination. These new data could help improving vaccination protocols.

Renson et al., 2019 - Maternally-derived neutralizing antibodies reduce vaccine efficacy against PRRSV infection- publication scientifique elevage porcin